Evidence mapPaperPMID 41001946Full record

ReviewCancer medicine2025

Roles of miR-181 Family Members in OSCC: Implications for Therapy and Diagnostics.

Alexandra Iulia Aghiorghiesei, Andreea Nutu, Nikolay Mehterov, Christos K Kontos, Boyan Vladimirov, Rares Buduru, Cornelia Braicu, Ioana Berindan-Neagoe

Abstract readReview
In one paragraph

Review in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexandra Iulia AghiorghieseiDepartment of Prosthodontics and Dental Materials, Faculty of Dental Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Andreea NutuResearch Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Nikolay MehterovDepartment of Medical Biology, Medical University-Plovdiv, Plovdiv, Bulgaria.
Christos K KontosDepartment of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.ORCID https://orcid.org/0000-0002-9935-8461
Boyan VladimirovDepartment of Maxillofacial Surgery, Medical University-Plovdiv, Plovdiv, Bulgaria.
Rares BuduruStomestet Clinic, Cluj-Napoca, Romania.
Cornelia BraicuResearch Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0002-3055-4747
Ioana Berindan-NeagoeDoctoral School, The Iuliu Hatieganu University of Medicine and Pharmacy -Cluj-Napoca, Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0001-5828-1325

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) is a common and aggressive form of head and neck cancer, frequently associated with smoking, alcohol consumption, and HPV infection. MicroRNAs (miRNAs) are small, non-coding RNA transcripts that play significant roles in cancer initiation and progression. In this study, we focused on the miR-181 family members' influence on OSCC tumorigenesis and progression, focusing on their distinct biological functions and regulatory mechanisms in OSCC-specific contexts. Attention was given to the potential of these transcripts as biomarkers, considering their differential expression in OSCC tissues and biofluids such as plasma, serum, and saliva. Alterations in salivary miR-181 levels have been correlated with different stages of oral lesion progression, underscoring their utility as non-invasive biomarkers for early detection and risk stratification. Moreover, we discuss the implications of miR-181 family modulation on biological processes in preclinical OSCC studies, highlighting their involvement in cancer hallmarks, including invasion, migration, metastasis, radio- and chemotherapy resistance. These findings underscore the therapeutic and diagnostic potential of the miR-181 family in OSCC management.

Indexed as

Biomarkers, TumorCarcinoma, Squamous CellMicroRNAsMouth NeoplasmsSquamous Cell Carcinoma of Head and NeckAnimalsGene Expression Regulation, NeoplasticHumansBiomarkers, TumorMicroRNAsMIrn181 microRNA, human

Identifiers

PMID41001946
PMCPMC12464875

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.